Quantifying Respiratory Viruses in Wastewater Using GT Molecular's Digital PCR Assays coupled with Ceres Nanosciences' Nanotrap® Particle Technology, the ThermoFisher MagMAX™ Microbiome Ultra Nucleic Acid Isolation Kit, and the KingFisher™ Apex Extraction Workflow™
Key Advantages
High-throughput multiplex detection coupling GT Molecular Digital PCR
Assays with the Nanotrap Partice Capture and Concentration Methods
Ability to co-monitor and co-quantify multiple pathogens Assays available for the QIAGEN QIAcuity®
Respiratory virus detection including Influenza A, Influenza B, and RSV in addition to SARS-CoV-2
Introduction
Monitoring the spread of SARS-CoV-2, the virus that causes COVID-19, as well as other pathogens such as RSV and Influenza continues to provide vital information for interrupting chains of transmission and preventing or dampening the spread of new cases. Wastewater testing continues to gain traction as a viable means to monitor pathogens and provide timely information about the changing prevalence within individual communities. Wastewater-based epidemiology (WBE) utility has already been successfully described to track infectious diseases like hepatitis, norovirus, and polio. Viral shedding detected in wastewater often precedes case upticks in healthcare settings, providing valuable and rapid information about infection within a community. Multiple countries have implemented wastewater-based monitoring of SARS-CoV-2, and the COVID-19 case rates highly correlate with SARS-CoV-2 RNA found in wastewater. However, these upper-respiratory viruses are often found at low concentrations within wastewater, thereby necessitating a concentration step. Nanotrap Particles, coupled with GT Molecular kits, provide end users with a high-throughput and sensitive means to monitor pathogens such as SARS-CoV-2, Influenza, and RSV.
APPLICATION NOTE SKU 10XXX SKU 44XXX
Comentarios